APEX1 and cancer: Data not shown from our laboratory (Codrich et al., submitted) clearly demonstrated that the inhibition of the APE1 endonuclease activity by Compound #3, in different cancer cell lines including HCC70 and HCC1937, causes a reduction of cell viability in a p53-dependent manner, possibly involving nucleolar stress and impairment of ribosome biogenesis [43].